Qi Jiang

Journal of Clinical Oncology · 2010–2011

A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from Qi Jiang's perspective

Ordered by how strongly the researchers Qi Jiang trusts endorse each paper. Same corpus, a different order for every researcher.

  1. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. (Journal of Clinical Oncology)
  2. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. (Cancer Journal)
  3. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. (Journal of the National Cancer Institute)
  4. Denosumab in postmenopausal women with low bone mineral density. (New England Journal of Medicine)
  5. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. (New England Journal of Medicine)
  6. Mechanisms of bone metastasis. (Discover medicine)
  7. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. (Journal of the National Cancer Institute)
  8. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. (Journal of Clinical Oncology)

Their papers